MAINTENANCE THERAPY
Clinical trials for MAINTENANCE THERAPY explained in plain language.
Never miss a new study
Get alerted when new MAINTENANCE THERAPY trials appear
Sign up with your email to follow new studies for MAINTENANCE THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to keep leukemia in remission
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own leukemia cells to help prevent the cancer from coming back. It is for adults with acute myeloid leukemia who are in remission after initial chemotherapy. The vaccine is designed to train the immune system to recogn…
Matched conditions: MAINTENANCE THERAPY
Phase: PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 17, 2026 01:50 UTC
-
New hope for AML patients: targeted drug may outperform standard care after transplant
Disease control Recruiting nowThis study tests whether the drug gilteritinib works better than sorafenib at keeping leukemia from coming back in people with a specific genetic mutation (FLT3-ITD) after a stem cell transplant. About 594 participants will be randomly assigned to take one of the two drugs for up…
Matched conditions: MAINTENANCE THERAPY
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 01:50 UTC
-
New drug combo aims to keep leukemia in remission after transplant
Disease control Recruiting nowThis study looks at whether menin inhibitors can help prevent leukemia from coming back after a stem cell transplant. About 20 people with certain genetic types of acute leukemia will take these drugs as part of their regular care. Researchers will track how long they stay cancer…
Matched conditions: MAINTENANCE THERAPY
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 01:49 UTC